SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018685
Filing Date
2019-05-13
Accepted
2019-05-13 09:01:29
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grts-10q_20190331.htm 10-Q 2291859
2 EX-31.1 grts-ex311_11.htm EX-31.1 19642
3 EX-31.2 grts-ex312_10.htm EX-31.2 19656
4 EX-32.1 grts-ex321_9.htm EX-32.1 13323
  Complete submission text file 0001564590-19-018685.txt   7899598

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT grts-20190331.xml EX-101.INS 1689383
6 XBRL TAXONOMY EXTENSION SCHEMA grts-20190331.xsd EX-101.SCH 62146
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grts-20190331_cal.xml EX-101.CAL 49826
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grts-20190331_def.xml EX-101.DEF 157990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20190331_lab.xml EX-101.LAB 438175
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20190331_pre.xml EX-101.PRE 330130
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 19817010
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences